At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer
갈림길에서: COVID-19와 암에 대한 면역 관문 차단
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antiviral immune response
antiviral immune responses
blockade
Cancer
Characteristics
clinical trials
Complication
complications of COVID-19
coronavirus
coronavirus disease
Coronavirus disease 2019
Course
COVID-19
COVID-19 infection
COVID-19 pandemic
COVID-19 vaccination
death
decrease
detrimental
disease course
Effect
Evidence
expression
heterogeneity
immune responses
immunomodulatory effect
immunomodulatory effects
infections
Inflammatory
inflammatory complications
Inflammatory response
Inflammatory responses
interferon
interferon signaling
leads
Ligand
MOST
pathway
Patient
patients
Patients with cancer
PD-L1
PD1
PROTECT
provided
receiving
receptor
respiratory
respiratory distress
Respiratory distress syndrome
RNA virus
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
Severe case
severe cases
Severe respiratory distress
Support
syndrome
the disease
therapy
Viral
viral infection
virus infections
worsening
[DOI] 10.1158/2326-6066.CIR-21-0008 PMC 바로가기 [Article Type] Article
[DOI] 10.1158/2326-6066.CIR-21-0008 PMC 바로가기 [Article Type] Article